Viatris (VTRS) Long-Term Deferred Tax (2019 - 2026)
Viatris (VTRS) posted quarterly Long-Term Deferred Tax of $1.1 billion for Q1 2026, up 35.67% year-over-year from $817.6 million in Q1 2025, and up 4.52% quarter-over-quarter from $1.1 billion in Q4 2025.
Viatris (VTRS) Long-Term Deferred Tax (2019 - 2026) Analysis & Trends
Viatris' Long-Term Deferred Tax history runs 8 years deep, the most recent figure standing at $1.1 billion for Q1 2026.
- In Q1 2026, Long-Term Deferred Tax rose 35.67% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 35.67% YoY), while the FY2025 annual figure was $1.1 billion, up 40.93% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $1.1 billion, up from $1.1 billion in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $1.3 billion in Q1 2022, with the low at $653.2 million in Q1 2024.
- The 5-year median for Long-Term Deferred Tax is $930.4 million (2023), against an average of $933.7 million.
- The sharpest annual moves came in 2022 and 2025: Long-Term Deferred Tax sank 43.07% in 2022, then surged 40.93% in 2025.
- Viatris' Long-Term Deferred Tax stood at $925.9 million in 2022, then fell by 25.16% to $692.9 million in 2023, then rose by 8.67% to $753.0 million in 2024, then soared by 40.93% to $1.1 billion in 2025, then rose by 4.52% to $1.1 billion in 2026.
- Business Quant data shows VTRS's Long-Term Deferred Tax at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $999.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Bn |
| Mar 31, 2026 | 1.11 Bn |
| Dec 31, 2025 | 1.06 Bn |
| Sep 30, 2025 | 999.00 Mn |
| Jun 30, 2025 | 924.30 Mn |
| Mar 31, 2025 | 817.60 Mn |
| Dec 31, 2024 | 753.00 Mn |
| Sep 30, 2024 | 763.10 Mn |
| Jun 30, 2024 | 685.30 Mn |
| Mar 31, 2024 | 653.20 Mn |
| Dec 31, 2023 | 692.90 Mn |
| Sep 30, 2023 | 930.40 Mn |
| Jun 30, 2023 | 966.00 Mn |
| Mar 31, 2023 | 959.10 Mn |
| Dec 31, 2022 | 925.90 Mn |
| Sep 30, 2022 | 1.10 Bn |
| Jun 30, 2022 | 1.24 Bn |
| Mar 31, 2022 | 1.29 Bn |
| Dec 31, 2021 | 1.33 Bn |
| Sep 30, 2021 | 1.45 Bn |